The administration of Provenge involves a multi-step process. First, a leukapheresis procedure is performed to collect the patient's immune cells. These cells are sent to a manufacturing facility where they are activated and then returned to the clinic for infusion into the patient. This process is typically repeated three times, with infusions spaced about two weeks apart.
